Shares of Eastgate Biotech Corp. (OTCMKTS:ETBI – Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. Eastgate Biotech shares last traded at $0.00, with a volume of 132,000 shares.
Eastgate Biotech Stock Performance
About Eastgate Biotech
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes.
Featured Articles
- Five stocks we like better than Eastgate Biotech
- How to Invest in Small Cap Stocks
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- Using the MarketBeat Dividend Tax Calculator
- CarMax Gets in Gear: Is Now the Time to Buy?
- Most active stocks: Dollar volume vs share volume
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Eastgate Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastgate Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
